|
× |
 |
DEXTROSE MONOHYDRATE Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
DOCUSATE SODIUM Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
ENTRESTO (sacubitril; valsartan) Drug Profile, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
SHELLAC Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
CELLULOSE, MICROCRYSTALLINE Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
EGATEN (triclabendazole) Drug Profile, 2024 |
$699.00 |
|
$699.00 |
|
|